Research and Markets: Global Stem Cell Anticancer Therapeutics Market 2012-2016 with Roche Holding AG, Teva …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/7wm2h9/global_stem_cell) has announced the addition of the "Global Stem Cell Anticancer Therapeutics Market 2012-2016" report to their offering.

The analysts forecast the Global Stem Anticancer Therapeutics market to grow at a CAGR of 11.48 percent over the period 2012-2016. Increasing investment in R&D is one of the key factors contributing to this market growth. The Global Stem Anticancer Therapeutics market has also been witnessing an increasing number of strategic alliances among vendors. However, stringent regulatory approval processes could pose a challenge to the growth of this market.

The key vendors dominating this space include Celgene Corp., Curis Inc., Exelixis Inc., Gamida Cell Ltd., Lonza Group, Merck & Co. Inc., OncoMed Pharmaceuticals Inc., Pfizer Inc., Roche Holding AG, Teva Pharmaceutical Industries Ltd., and Verastem Inc.

Key questions answered in this report:

- What will the market size be in 2016 and what will be the growth rate?

- What are key market trends?

- What is driving this market?

- What are the challenges to market growth?

- Who are the key vendors in this market space?

Read more:
Research and Markets: Global Stem Cell Anticancer Therapeutics Market 2012-2016 with Roche Holding AG, Teva ...